Prescription drug · ANDA
sodium nitroprusside in 0.9% sodium chloride NDC 70436-205
Sodium nitroprusside .2 mg/mL · Injection · Intravenous · Slate Run Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70436-205-80 | 7043602058070436020580 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-205-80) / 50 mL in 1 VIAL, SINGLE-DOSEMarketed from Dec 31, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- sodium nitroprusside in 0.9% sodium chloride
- Generic name (nonproprietary)
- sodium nitroprusside in 0.9% sodium chloride
- Active ingredients
- Sodium nitroprusside — .2 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Slate Run Pharmaceuticals, LLCNDC labeler code 70436
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215846
- Marketing start
- Listing expires
- Other FDA classes
- Vasodilation (Physiologic effect)
- Identifiers
- Product ID 70436-205_09c94d69-7bea-2491-e063-6394a90a6438SPL ID 09c94d69-7bea-2491-e063-6394a90a6438SPL set ID 6f02e4ac-5f7c-4003-b9b7-283f489cddb0RxCUI 1876368, 1999185, 2052423UNII EAO03PE1TCUPC 0370436206803
- Pharmacologic class
- Vasodilator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470436020580followed by a unit qualifier and the quantityPackage 70436-0205-80. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Sodium nitroprusside is a direct acting vasodilator indicated for: Immediate reduction of blood pressure ( 1.1 ) Producing controlled hypotension to reduce bleeding during surgery ( 1.2 ) Treatment of acute heart failure to reduce left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance and mean arterial blood pressure ( 1.3 ) 1.1 Immediate Reduction of Blood Pressure Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. 1.2 Induction and Maintenance of Controlled Hypotension Sodium nitroprusside indicated for induction and maintenance of controlled hypotension…
Excerpt only. Read the full label for complete information.
About NDC 70436-205
- What is NDC 70436-205?
- 70436-205 is the product NDC for sodium nitroprusside in 0.9% sodium chloride, Sodium nitroprusside .2 mg/mL injection, listed with the FDA by Slate Run Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- sodium nitroprusside in 0.9% sodium chloride.
- What is the active ingredient?
- Sodium nitroprusside.
- Who is the labeler?
- Slate Run Pharmaceuticals, LLC, NDC labeler code 70436. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for sodium nitroprusside in 0.9% sodium chloride?
- 2 other product NDCs are listed under this name. See all sodium nitroprusside in 0.9% sodium chloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other sodium nitroprusside in 0.9% sodium chloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| sodium nitroprusside in 0.9% sodium chloride | Sodium nitroprusside .2 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-206 | 70436-0206-80 |
| sodium nitroprusside in 0.9% sodium chloride | Sodium nitroprusside .5 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-207 | 70436-0207-80 |
Other NDCs under ANDA 215846
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sodium Nitroprusside | Sodium nitroprusside .2 mg/mL | Injection, SolutionIntravenous | Hainan Poly Pharm. Co., Ltd. | 14335-132 |
| Sodium Nitroprusside | Sodium nitroprusside .2 mg/mL | Injection, SolutionIntravenous | Hainan Poly Pharm. Co., Ltd. | 14335-133 |
| Sodium Nitroprusside | Sodium nitroprusside .5 mg/mL | Injection, SolutionIntravenous | Hainan Poly Pharm. Co., Ltd. | 14335-134 |
| sodium nitroprusside in 0.9% sodium chloride | Sodium nitroprusside .2 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-206 |
| sodium nitroprusside in 0.9% sodium chloride | Sodium nitroprusside .5 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-207 |